Health
Continue to drive global industrial innovation to
create a medical-grade, one-stop, all-scenario health ecosystem
In the first half of 2024, 4 key innovative products with a total of 9 indications were approved for marketing
and 4 products with a total of 9 indications had entered the pre-launch approval stage/ key clinical stage
Medical aesthetics, respiratory health, professional medical devices, and medical diagnosis
Focusing on high-quality medical and professional services, the offerings include combined insurance,
health consumption, and wellness solutions, designed to create a comprehensive closed-loop solution
A Core Company In The Health Segment
A global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China
Fosun Pharma directly operates businesses including pharmaceuticals, medical devices, medical diagnosis, and healthcare services.
As a shareholder of Sinopharm Co., Ltd., Fosun Pharma expands its areas in the pharmaceutical distribution and retail business.
-
20.383billion
1H2024 Revenue
-
5.51billion
Overseas revenue
-
2.737billion
1H2024 R&D investment
-
3,200+
R&D personnel
-
Pharmaceuticals
Innovative drugs
Mature products and manufacturing
Vaccine -
Medical Devices and Medical Diagnosis
Medical devices
Medical diagnosis -
Healthcare Services
Online medical service platform
Offline medical institutions
(including rehabilitation medical institutions)
